Cover Image
市場調查報告書

Ascendis Pharma A/S的產品平台分析

Ascendis Pharma A/S - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256086
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Ascendis Pharma A/S的產品平台分析 Ascendis Pharma A/S - Product Pipeline Review - 2015
出版日期: 2015年04月29日 內容資訊: 英文 33 Pages
簡介

Ascendis Pharma A/S是總公司位於丹麥的生物科技企業,藉由利用Transcon前驅藥物技術平台,來開發由前驅藥物分化的高附加價值製劑。主要的治療領域是內分泌系統、中樞神經系統、感染疾病。

本報告提供Ascendis Pharma A/S的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Ascendis Pharma A/S的基本資料

  • Ascendis Pharma A/S概要
  • 主要資訊
  • 企業資料

Ascendis Pharma A/S:R&D概要

  • 主要的治療範圍

Ascendis Pharma A/S:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Ascendis Pharma A/S:開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Ascendis Pharma A/S:藥物簡介

  • ACP-001
  • ACP-005
  • ACP-006
  • ACP-007
  • ACP-008

Ascendis Pharma A/S:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Ascendis Pharma A/S:最新的開發平台資訊

Ascendis Pharma A/S:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07023CDB

Summary

Global Markets Direct's, 'Ascendis Pharma A/S - Product Pipeline Review - 2015', provides an overview of the Ascendis Pharma A/S's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ascendis Pharma A/S's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Ascendis Pharma A/S including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ascendis Pharma A/S's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ascendis Pharma A/S's pipeline products

Reasons to buy

  • Evaluate Ascendis Pharma A/S's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ascendis Pharma A/S in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ascendis Pharma A/S's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ascendis Pharma A/S and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ascendis Pharma A/S
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ascendis Pharma A/S and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ascendis Pharma A/S Snapshot
    • Ascendis Pharma A/S Overview
    • Key Information
    • Key Facts
  • Ascendis Pharma A/S - Research and Development Overview
    • Key Therapeutic Areas
  • Ascendis Pharma A/S - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Ascendis Pharma A/S - Pipeline Products Glance
    • Ascendis Pharma A/S - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Ascendis Pharma A/S - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Ascendis Pharma A/S - Drug Profiles
    • ACP-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • treprostinil
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACP-005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • pramipexole dihydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACP-007
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACP-008
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ascendis Pharma A/S - Pipeline Analysis
    • Ascendis Pharma A/S - Pipeline Products by Target
    • Ascendis Pharma A/S - Pipeline Products by Route of Administration
    • Ascendis Pharma A/S - Pipeline Products by Molecule Type
    • Ascendis Pharma A/S - Pipeline Products by Mechanism of Action
  • Ascendis Pharma A/S - Recent Pipeline Updates
  • Ascendis Pharma A/S - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ascendis Pharma A/S, Key Information
  • Ascendis Pharma A/S, Key Facts
  • Ascendis Pharma A/S - Pipeline by Indication, 2015
  • Ascendis Pharma A/S - Pipeline by Stage of Development, 2015
  • Ascendis Pharma A/S - Monotherapy Products in Pipeline, 2015
  • Ascendis Pharma A/S - Partnered Products in Pipeline, 2015
  • Ascendis Pharma A/S - Partnered Products/ Combination Treatment Modalities, 2015
  • Ascendis Pharma A/S - Out-Licensed Products in Pipeline, 2015
  • Ascendis Pharma A/S - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Ascendis Pharma A/S - Phase II, 2015
  • Ascendis Pharma A/S - Phase I, 2015
  • Ascendis Pharma A/S - Preclinical, 2015
  • Ascendis Pharma A/S - Discovery, 2015
  • Ascendis Pharma A/S - Pipeline by Target, 2015
  • Ascendis Pharma A/S - Pipeline by Route of Administration, 2015
  • Ascendis Pharma A/S - Pipeline by Molecule Type, 2015
  • Ascendis Pharma A/S - Pipeline Products by Mechanism of Action, 2015
  • Ascendis Pharma A/S - Recent Pipeline Updates, 2015
  • Ascendis Pharma A/S, Subsidiaries

List of Figures

  • Ascendis Pharma A/S - Pipeline by Top 10 Indication, 2015
  • Ascendis Pharma A/S - Pipeline by Stage of Development, 2015
  • Ascendis Pharma A/S - Monotherapy Products in Pipeline, 2015
  • Ascendis Pharma A/S - Out-Licensed Products in Pipeline, 2015
  • Ascendis Pharma A/S - Pipeline by Top 10 Target, 2015
  • Ascendis Pharma A/S - Pipeline by Top 10 Route of Administration, 2015
  • Ascendis Pharma A/S - Pipeline by Top 10 Molecule Type, 2015
  • Ascendis Pharma A/S - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top